» Articles » PMID: 16493051

Unique Structural Determinants for Stat3 Recruitment and Activation by the Granulocyte Colony-stimulating Factor Receptor at Phosphotyrosine Ligands 704 and 744

Overview
Journal J Immunol
Date 2006 Feb 24
PMID 16493051
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

G-CSFR cytoplasmic tyrosine (Y) residues (Y704, Y729, Y744, and Y764) become phosphorylated upon ligand binding and recruit specific Src homology 2 domain-containing proteins that link to distinct yet overlapping programs for myeloid cell survival, differentiation, proliferation, and activation. The structural basis for recruitment specificity is poorly understood but could be exploited to selectively target deleterious G-CSFR-mediated signaling events such as aberrant Stat3 activation demonstrated in a subset of acute myeloid leukemia patients with poor prognosis. Recombinant Stat3 bound to G-CSFR phosphotyrosine peptide ligands pY704VLQ and pY744LRC with similar kinetics. Testing of three models for Stat3 Src homology 2-pY ligand binding in vitro and in vivo revealed unique determinants for Stat3 recruitment and activation by the G-CSFR, the side chain of Stat3 R609, which interacts with the pY ligand phosphate group, and the peptide amide hydrogen of E638, which bonds with oxygen/sulfur within the + 3 Q/C side chain of the pY ligand when it assumes a beta turn. Thus, our findings identify for the first time the structural basis for recruitment and activation of Stat3 by the G-CSFR and reveal unique features of this interaction that can be exploited to target Stat3 activation for the treatment of a subset of acute myeloid leukemia patients.

Citing Articles

IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy.

Jiang H, Limsuwannarot S, Kulhanek K, Pal A, Rysavy L, Su L bioRxiv. 2025; .

PMID: 39868284 PMC: 11760723. DOI: 10.1101/2025.01.15.633105.


DRUGGING "UNDRUGGABLE" DISEASE-CAUSING PROTEINS: FOCUS ON SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 3.

Tweardy D Trans Am Clin Climatol Assoc. 2022; 132:61-76.

PMID: 36196170 PMC: 9480546.


A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer.

Park S, Saunders A, Reidy M, Bender D, Clifton S, Morris K Front Oncol. 2022; 12:932608.

PMID: 36033452 PMC: 9402976. DOI: 10.3389/fonc.2022.932608.


Methods for the Discovery and Identification of Small Molecules Targeting Oxidative Stress-Related Protein-Protein Interactions: An Update.

Wu X, Zhang Q, Guo Y, Zhang H, Guo X, You Q Antioxidants (Basel). 2022; 11(4).

PMID: 35453304 PMC: 9025695. DOI: 10.3390/antiox11040619.


Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway.

Panipinto P, Singh A, Shaikh F, Siegel R, Chourasia M, Ahmed S Int J Mol Sci. 2021; 22(22).

PMID: 34830460 PMC: 8621335. DOI: 10.3390/ijms222212580.